PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

A novel CX3CR1 inhibitor AZD8797 facilitates early recovery of rat acute spinal cord injury by inhibiting inflammation and apoptosis.

Rat / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32323731 ↗2020Reported benefit

A novel CX3CR1 inhibitor AZD8797 facilitates early recovery of rat acute spinal cord injury by inhibiting inflammation and apoptosis.

RatSpinal cord injuryCompressionSprague-DawleyMalen = 75 rats used, 65 analysed; subset I 25 rats in 5 groups (n=…Intraperitoneal injection80 micrograms/kg, dissolved in DMSOAfter spinal cord injury; exact interval not stated (positive control methylpre…

Model: Clip compression spinal cord injury at T10 using a clamp with 30 g closing pressure applied for 20 seconds after laminectomy

AZD8797 improved locomotor recovery at 10 days after injury to a degree comparable with methylprednisolone. Benefit was accompanied by reduced apoptosis and necrosis and lower serum TNF-alpha, IL-6 and IL-1beta.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.92. Machine-extracted fields require source verification.